Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Redfield

Showing results (711-720 of 1,078) with videos related to

Pageof 108
Sort By:
Journal of Cardiac Failure|July 14, 2023
Changes in Kidney Function After Diagnosis of Advanced Heart FailureBenjamin J Quiram, Jill M Killian, Margaret M Redfield, et al.
Journal of Pain and Symptom Management|July 19, 2015
Implementation of HIV Palliative Care: Interprofessional Education to Improve Patient Outcomes in Resource-Constrained Settings, 2004-2012Carla S Alexander, Gregory Pappas, Anthony Amoroso, et al.
Transplantation Direct|March 15, 2018
Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney TransplantationSandesh Parajuli, Didier A Mandelbrot, Brenda Muth, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2015
Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized miceAlonso Heredia, Nhut Le, Ronald B Gartenhaus, et al.
International Journal of STD & AIDS|April 7, 2018
Patient-level outcomes and virologic suppression rates in HIV-infected patients receiving antiretroviral therapy in RwandaDavid J Riedel, Kristen A Stafford, Peter Memiah, et al.
AIDS Research and Human Retroviruses|May 18, 2019
Suppression of Active HIV-1 Infection in CD34<sup>+</sup> Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting DrugsOlga S Latinovic, Lauren M Neal, Yutaka Tagaya, et al.
Journal of the International Association of Providers of AIDS Care|December 17, 2014
Long-term outcome of second-line antiretroviral therapy in resource-limited settingsOlukemi Osinusi-Adekanmbi, Kristen Stafford, Adiba Ukpaka, et al.
HIV Clinical Trials|January 9, 2007
Once-daily abacavir/lamivudine/zidovudine plus tenofovir for the treatment of HIV-1 infection in antiretroviral-naïve subjects: a 48-week pilot studyRichard Elion, Calvin Cohen, Edwin DeJesus, et al.
Journal of the American College of Cardiology|May 8, 2010
The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjectsPaul M McKie, Alessandro Cataliotti, Brian D Lahr, et al.
JACC. Heart Failure|February 12, 2026
Progression From Exercise-Induced to Resting Left Atrial Hypertension in HFpEF: Impact of Reduced Atriopulmonary ComplianceAtsushi Tada, Jwan A Naser, Shunichi Doi, et al.
Pageof 108

Showing results (711-720 of 1,078) with videos related to

Sort By:
Pageof 108
Journal of Cardiac Failure|July 14, 2023
Changes in Kidney Function After Diagnosis of Advanced Heart FailureBenjamin J Quiram, Jill M Killian, Margaret M Redfield, et al.
Journal of Pain and Symptom Management|July 19, 2015
Implementation of HIV Palliative Care: Interprofessional Education to Improve Patient Outcomes in Resource-Constrained Settings, 2004-2012Carla S Alexander, Gregory Pappas, Anthony Amoroso, et al.
Transplantation Direct|March 15, 2018
Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney TransplantationSandesh Parajuli, Didier A Mandelbrot, Brenda Muth, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2015
Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized miceAlonso Heredia, Nhut Le, Ronald B Gartenhaus, et al.
International Journal of STD & AIDS|April 7, 2018
Patient-level outcomes and virologic suppression rates in HIV-infected patients receiving antiretroviral therapy in RwandaDavid J Riedel, Kristen A Stafford, Peter Memiah, et al.
AIDS Research and Human Retroviruses|May 18, 2019
Suppression of Active HIV-1 Infection in CD34<sup>+</sup> Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting DrugsOlga S Latinovic, Lauren M Neal, Yutaka Tagaya, et al.
Journal of the International Association of Providers of AIDS Care|December 17, 2014
Long-term outcome of second-line antiretroviral therapy in resource-limited settingsOlukemi Osinusi-Adekanmbi, Kristen Stafford, Adiba Ukpaka, et al.
HIV Clinical Trials|January 9, 2007
Once-daily abacavir/lamivudine/zidovudine plus tenofovir for the treatment of HIV-1 infection in antiretroviral-naïve subjects: a 48-week pilot studyRichard Elion, Calvin Cohen, Edwin DeJesus, et al.
Journal of the American College of Cardiology|May 8, 2010
The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjectsPaul M McKie, Alessandro Cataliotti, Brian D Lahr, et al.
JACC. Heart Failure|February 12, 2026
Progression From Exercise-Induced to Resting Left Atrial Hypertension in HFpEF: Impact of Reduced Atriopulmonary ComplianceAtsushi Tada, Jwan A Naser, Shunichi Doi, et al.
Pageof 108